The maker of Mifeprex, the brand version of abortion pill mifepristone, indicated it’s open to adding miscarriage as a use on the label—if it can still market the drug after a Texas judge blocked it.
Danco Laboratories LLC would not be able to change the label if Mifeprex were suspended or withdrawn from the market, a company spokesperson said.
“We believe other indications, including miscarriage management, are important for patients in the US. Although we have limited options now, we are considering continued activity in this area,” Abby Long, spokesperson for Danco, wrote in an email.
Mifepristone is widely ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
